SCHEMBL19115356

SCHEMBL19115356

CCCC(CC)C(=O)OC1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 2/20 0.54
CHRM3 P20309 2/20 0.54
ADRA1A P35348 2/20 0.54
CHRM2 P08172 1/20 0.54
CHRNA4 P43681 1/20 0.54
HTR3A P46098 1/20 0.54
KCNH2 Q12809 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
NAAA Q02083 2/20 0.45
EPHX1 P07099 2/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CYP19A1 P11511 1/20 0.39
AKR1A1 P14550 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HRH1 P35367 1/20 0.38
DRD3 P35462 1/20 0.38
SLC6A3 Q01959 1/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7224472 0.98 CHRM1 (0.53) CHRM1CHRM3ADRA1ACHRM2CHRNA4
SCHEMBL20170459 0.98 CHRM1 (0.53) CHRM1CHRM3ADRA1ACHRM2CHRNA4
SCHEMBL20170447 0.98 CHRM1 (0.53) CHRM1CHRM3ADRA1ACHRM2CHRNA4
SCHEMBL7217444 0.91 CHRM1 (0.59) CHRM1CHRM3ADRA1ACHRM2CHRNA4
SCHEMBL14875486 0.89 EPHX1 (0.48) CHRM1CHRM3ADRA1ACHRM2CHRNA4
SCHEMBL3908224 0.88 CA2 (0.54) CHRM1CHRM3ADRA1ACHRM2CHRNA4
SCHEMBL22086821 0.88 EPHX1 (0.42) CHRM1CHRM3ADRA1ACHRM2CHRNA4
SCHEMBL5827222 0.87 EPHX1 (0.52) CHRM1CHRM3ADRA1ACHRM2CHRNA4
SCHEMBL27864138 0.87 NAAA (0.55) CHRM1CHRM3ADRA1ACHRM2CHRNA4
Ammonia Solution, Strong SCHEMBL11651733 0.87 CA2 (0.53) CHRM1CHRM3ADRA1ACHRM2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170196848-A1 Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives ALKERMES PHARMA IRELAND LTD (IE) 2017-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170196848-A1 Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives PHPT1, SI, CA6 CHRM1 2813/4885CHRM3 3013/4885ADRA1A 4523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.